Skip to content

Friends Joins Organizations in Support of Dr. Robert Califf’s Nomination to FDA Commissioner

Friends Joins Organizations in Support of Dr. Robert Califf’s Nomination to FDA Commissioner

In support of Dr. Robert Califf’s recent nomination to FDA Commissioner, Friends has joined with numerous other organizations to urge the Senate towards immediate confirmation for Dr. Califf.

Full text of the letter is below. Access a PDF version HERE.

Dear Chairman Alexander and Ranking Member Murray:

The undersigned organizations, representing millions of patients, advocates, caregivers and health care providers would like to enthusiastically endorse President Obama’s nomination of Dr. Robert Califf as Commissioner of the Food and Drug Administration (FDA). We ask that the Senate take immediate action to confirm Dr. Califf.

The United States is at a pivotal moment in terms of public health, and the leadership that Dr. Califf will bring to the FDA will be paramount to assuring the safety, effectiveness, and security of human drugs, and helping to speed innovations that make medicines more effective, safer, and more affordable.

Dr. Califf’s career has focused on vital issues that directly impact patients’ lives. As Vice Chancellor of Clinical and Translational Research at Duke University, Dr. Califf led numerous landmark clinical studies. He became a nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality, and clinical research. He is one of the nation’s leaders in the growing field of translational research – key to making sure advances in science translate into medical care.

Dr. Califf also has had vast experience working with FDA. Prior to his appointment to Deputy Commissioner for Medical Products and Tobacco, he served as a member of the FDA Cardiorenal Advisory Panel and FDA Science Board’s Subcommittee on Science and Technology. His prior work with the agency will prove invaluable and beneficial.

We believe that with Dr. Califf’s diverse background, and his exemplary knowledge of clinical and translational medicine, he will continue to improve the FDA’s drug approval process while ensuring that patients are receiving the safest and most effective treatments as quickly as possible. We urge his immediate confirmation.


Action to Cure Kidney Cancer (ACKC)

Addario Lung Cancer Medical Institute (ALCMI)

Alliance for Aging Research

The ALS Association

Alpha-1 Foundation

American Academy of Pediatrics

American Association for Cancer Research (AACR)

American Cancer Society Cancer Action Network

American Society of Clinical Oncology (ASCO)

Association of American Cancer Institutes (AACI)

Bert’s Big Adventure

Bonnie J. Addario Lung Cancer Foundation

Cancer Support Community


Center for Medical Technology Policy

CEO Roundtable on Cancer

Chase After a Cure

Childhood Cancer Guides

COPD Foundation

DC Candlelighters Childhood Cancer Foundation

Eastern Cooperative Oncology Group (ECOG)

Facing Our Risk of Cancer Empowered (FORCE)


Fight Colorectal Cancer

Friends of Cancer Research

Grandparents In Action

Hematology/Oncology Pharmacy Association

Institute of Catholic Bioethics


Kids v. Cancer

Lung Cancer Alliance


Lupus and Allied Diseases Association

Martin Truex Jr. Foundation

Mattie Miracle Cancer Foundation

Men’s Health Network

National Alliance on Mental Illness (NAMI)

National Brain Tumor Society

National Organization for Rare Disorders (NORD)

National Patient Advocate Foundation

Oncology Nursing Society


Personalized Medicine Coalition

Prevent Cancer Foundation

Society for Women’s Health Research (SWHR)

Solving Kids’ Cancer

Sophia’s Fund

St. Baldrick’s Foundation

Stand Up To Cancer

The Swifty Foundation